Loss of beclin 1 expression in ovarian cancer: A potential biomarker for predicting unfavorable outcomes.
Minamoto T, Nakayama K, Nakamura K, Katagiri H, Sultana R, Ishibashi T, Ishikawa M, Yamashita H, Sanuki K, Iida K, Nakayama S, Otsuki Y, Ishikawa N, Kyo S.
Minamoto T, et al. Among authors: yamashita h.
Oncol Lett. 2018 Jan;15(1):1170-1176. doi: 10.3892/ol.2017.7379. Epub 2017 Nov 9.
Oncol Lett. 2018.
PMID: 29399172
Free PMC article.